HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ernst-Wilhelm Radue Selected Research

Alanine Transaminase (SGPT)

11/2014Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.
6/2014Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ernst-Wilhelm Radue Research Topics

Disease

27Multiple Sclerosis
01/2022 - 03/2006
17Relapsing-Remitting Multiple Sclerosis
10/2020 - 10/2007
5Psychotic Disorders (Schizoaffective Disorder)
01/2015 - 05/2010
4Progressive Multifocal Leukoencephalopathy
11/2012 - 03/2006
3Atrophy
09/2017 - 12/2004
2Heroin Dependence (Heroin Abuse)
12/2015 - 12/2015
2Hypertension (High Blood Pressure)
06/2014 - 02/2010
2Bradycardia
06/2014 - 02/2010
2Atrioventricular Block
06/2014 - 02/2010
2Disease Progression
02/2014 - 05/2010
2Immune Reconstitution Inflammatory Syndrome
11/2012 - 02/2012
1Peripheral Arterial Disease
01/2019
1Atrial Fibrillation
01/2019
1Pathologic Constriction (Stenosis)
01/2019
1Ulcerative Colitis
07/2016
1Urinary Tract Infections (Urinary Tract Infection)
07/2016
1Pneumonia (Pneumonitis)
07/2016
1Inflammation (Inflammations)
01/2016
1Dizziness (Lightheadedness)
11/2014
1Human Influenza (Influenza)
11/2014
1Sleep Initiation and Maintenance Disorders (Insomnia)
11/2014
1Lymphopenia (Lymphocytopenia)
06/2014
1Neoplasms (Cancer)
06/2014
1Infections
06/2014
1Herpes Zoster
06/2014
1Basal Cell Carcinoma (Rodent Ulcer)
06/2014
1Autoimmune Hepatitis
05/2014
1Exanthema (Rash)
06/2013
1Psoas Abscess
06/2013
1Channelopathies
02/2013
1Malnutrition (Nutritional Deficiencies)
05/2010
1Macular Edema
02/2010
1Rheumatoid Arthritis
03/2006
1Pharyngitis (Sore Throat)
03/2006
1Crohn Disease (Crohn's Disease)
03/2006
1Edema (Dropsy)
03/2006
1Stroke (Strokes)
09/2004
1Spinal Cord Injuries (Spinal Cord Injury)
09/2004

Drug/Important Bio-Agent (IBA)

12Fingolimod Hydrochloride (FTY720)FDA Link
01/2020 - 02/2010
8Natalizumab (Tysabri)FDA Link
07/2015 - 03/2006
5GadoliniumIBA
01/2017 - 12/2004
4Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2012
4Interferon beta-1aFDA Link
05/2010 - 03/2006
3Daclizumab (Zenapax)FDA Link
10/2020 - 06/2013
3Polytetrafluoroethylene (Teflon)FDA Link
01/2015 - 05/2010
3daclizumab HYPIBA
05/2014 - 06/2013
2teriflunomideIBA
01/2020 - 09/2017
2EnzymesIBA
07/2016 - 02/2010
2Immunoglobulin G (IgG)IBA
11/2015 - 02/2013
2Interferon beta-1b (Betaseron)FDA Link
11/2015 - 09/2007
2Alanine Transaminase (SGPT)IBA
11/2014 - 06/2014
2Antipsychotic Agents (Antipsychotics)IBA
12/2012 - 05/2010
2Pharmaceutical PreparationsIBA
02/2012 - 05/2010
2Interferon-betaIBA
03/2009 - 03/2006
1IronIBA
01/2022
1CholesterolIBA
01/2019
1Immunologic Factors (Immunomodulators)IBA
09/2017
1SaltsIBA
07/2017
1SodiumIBA
07/2017
1Opioid Analgesics (Opioids)IBA
12/2015
1Heroin (Diamorphine)IBA
12/2015
1CotinineIBA
11/2015
1Antidepressive Agents (Antidepressants)IBA
01/2015
1ponesimodIBA
11/2014
1Sphingosine-1-Phosphate ReceptorsIBA
11/2014
1Glutamic Acid (Glutamate)FDA Link
03/2013
1Genetic Markers (Genetic Marker)IBA
03/2013
1AntigensIBA
02/2013
1Aquaporin 4IBA
02/2013
1Histone Deacetylases (Histone Deacetylase)IBA
01/2013
1factor AIBA
05/2010
1BHT 3009IBA
05/2008
1VaccinesIBA
05/2008
1A-Form DNA (A-DNA)IBA
05/2008
1Myelin Basic ProteinIBA
05/2008
1Neuroprotective AgentsIBA
09/2004

Therapy/Procedure

7Therapeutics
01/2016 - 03/2006
1Aftercare (After-Treatment)
04/2015
1Subcutaneous Injections
06/2013